BIOTRICITY INC. Selling, General and Administrative Expense
BIOTRICITY INC. (BTCY) reported Selling, General and Administrative Expense of $2.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-19
- BIOTRICITY INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.70M, a 26.21% increase year-over-year.
- BIOTRICITY INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.86M, a 42.88% decline year-over-year.
- BIOTRICITY INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $2.19M, a 8.18% decline year-over-year.
- BIOTRICITY INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.30M, a 2.49% increase year-over-year.
- BIOTRICITY INC. selling, general and administrative expense for fiscal 2026 was $8.49M, a 21.78% decline from fiscal 2025.
- BIOTRICITY INC. selling, general and administrative expense for fiscal 2025 was $10.86M, a 25.70% decline from fiscal 2024.
- BIOTRICITY INC. selling, general and administrative expense for fiscal 2024 was $14.61M, a 17.08% decline from fiscal 2023.
- BIOTRICITY INC. selling, general and administrative expense for fiscal 2023 was $17.62M, a 5.07% decline from fiscal 2022.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-19 | $4.56M derived: sum of 2 quarters · filed 2026-08-19 | $6.75M derived: sum of 3 quarters · filed 2026-08-19 | $9.05M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $4.05M derived: sum of 2 quarters · filed 2026-07-14 | $6.35M derived: sum of 3 quarters · filed 2026-07-14 | $8.49M 10-K · filed 2026-07-14 |
| 2025-12-31 | $2.19M 10-Q · filed 2026-02-11 | $4.49M derived: sum of 2 quarters · filed 2026-02-11 | $6.63M 10-Q · filed 2026-02-11 | $9.89M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $2.30M 10-Q · filed 2025-11-14 | $4.44M 10-Q · filed 2025-11-14 | $7.70M derived: sum of 3 quarters · filed 2026-08-19 | $10.09M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $2.14M 10-Q · filed 2026-08-19 | $5.40M derived: sum of 2 quarters · filed 2026-08-19 | $7.78M derived: sum of 3 quarters · filed 2026-08-19 | $10.03M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $5.64M derived: sum of 2 quarters · filed 2026-07-14 | $7.89M derived: sum of 3 quarters · filed 2026-07-14 | $10.86M 10-K · filed 2026-07-14 |
| 2024-12-31 | $2.38M 10-Q · filed 2026-02-11 | $4.63M derived: sum of 2 quarters · filed 2026-02-11 | $7.60M 10-Q · filed 2026-02-11 | $12.21M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $2.25M 10-Q · filed 2025-11-14 | $5.21M 10-Q · filed 2025-11-14 | $9.82M derived: sum of 3 quarters · filed 2025-11-14 | $12.82M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $2.97M 10-Q · filed 2025-08-14 | $7.57M derived: sum of 2 quarters · filed 2025-08-14 | $10.57M derived: sum of 3 quarters · filed 2025-08-14 | $14.06M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.61M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-07-18 | $7.61M derived: sum of 2 quarters · filed 2025-07-18 | $11.09M derived: sum of 3 quarters · filed 2025-07-18 | $14.61M 10-K/A · filed 2025-07-18 |
| 2023-12-31 | $3.00M 10-Q/A · filed 2025-02-20 | $6.48M derived: sum of 2 quarters · filed 2025-02-20 | $10.00M 10-Q/A · filed 2025-02-20 | $14.29M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-09-30 | $3.49M 10-Q · filed 2024-11-14 | $7.01M 10-Q · filed 2024-11-14 | $11.29M derived: sum of 3 quarters · filed 2024-11-14 | $15.66M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $3.52M 10-Q · filed 2024-08-19 | $7.81M derived: sum of 2 quarters · filed 2024-08-19 | $12.17M derived: sum of 3 quarters · filed 2024-08-19 | $16.65M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-27 | $8.65M derived: sum of 2 quarters · filed 2024-06-27 | $13.13M derived: sum of 3 quarters · filed 2024-06-27 | $17.62M 10-K · filed 2024-06-27 |
| 2022-12-31 | $4.36M 10-Q · filed 2024-02-20 | $8.84M derived: sum of 2 quarters · filed 2024-02-20 | $13.34M 10-Q · filed 2024-02-20 | |
| 2022-09-30 | $4.48M 10-Q · filed 2023-11-14 | $8.97M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $4.49M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $18.56M 10-K · filed 2023-06-29 |